These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32802331)

  • 41. A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas.
    Ansari M; Omidvari S; Mosalaei A; Ahmadloo N; Mosleh-Shirazi MA; Mohammadianpanah M
    Iran Red Crescent Med J; 2011 Mar; 13(3):187-91. PubMed ID: 22737461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.
    Hitt R; Grau JJ; López-Pousa A; Berrocal A; García-Girón C; Irigoyen A; Sastre J; Martínez-Trufero J; Brandariz Castelo JA; Verger E; Cruz-Hernández JJ;
    Ann Oncol; 2014 Jan; 25(1):216-25. PubMed ID: 24256848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?
    Paccagnella A; Mastromauro C; D'Amanzo P; Ghi MG
    Oncologist; 2010; 15 Suppl 3():8-12. PubMed ID: 21036883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H; Tsukuda M; Watai K
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology.
    Alterio D; Cossu Rocca M; Russell-Edu W; Dicuonzo S; Fanetti G; Marvaso G; Preda L; Zorzi S; Verri E; Nole' F; Jereczek-Fossa BA
    Med Oncol; 2017 May; 34(5):86. PubMed ID: 28391578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EORTC 24051: unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma.
    Lalami Y; Specenier PM; Awada A; Lacombe D; Liberatoscioli C; Fortpied C; El-Hariry I; Bogaerts J; Andry G; Langendijk JA; Vermorken JB
    Radiother Oncol; 2012 Nov; 105(2):238-40. PubMed ID: 22989664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study).
    Zenda S; Ota Y; Kiyota N; Okano S; Fujii M; Kitamura M; Takahashi S; Ueda T; Monden N; Yamanaka T; Tahara M
    Front Oncol; 2019; 9():6. PubMed ID: 30723701
    [No Abstract]   [Full Text] [Related]  

  • 48. [Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
    Chilimoniuk M; Olszewska E; Maksimowicz T
    Pol Merkur Lekarski; 2010 Dec; 29(174):357-60. PubMed ID: 21298984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone in locally advanced head and neck cancer.
    Dhaka S; Jakhar SL; Sharma N; Kumar HS; Kumar R
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S146-S150. PubMed ID: 36510955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
    Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
    Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma.
    Uchinami Y; Yasuda K; Kano S; Otsuka M; Hamada S; Suzuki T; Tsushima N; Takahashi S; Fujita Y; Miyazaki T; Higaki H; Taguchi J; Shimizu Y; Sakashita T; Homma A; Aoyama H
    Discov Oncol; 2023 Dec; 14(1):226. PubMed ID: 38063923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck.
    Day D; Prawira A; Spreafico A; Waldron J; Karithanam R; Giuliani M; Weinreb I; Kim J; Cho J; Hope A; Bayley A; Ringash J; Bratman SV; Jang R; O'Sullivan B; Siu LL; Hansen AR
    Oral Oncol; 2020 Sep; 108():104753. PubMed ID: 32464516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancers.
    Baykara M; Buyukberber S; Ozturk B; Coskun U; Unsal DK; Demirci U; Dane F; Kaplan MA; Bora H; Benekli M
    Asian Pac J Cancer Prev; 2013; 14(4):2557-61. PubMed ID: 23725174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Addition of Nimotuzumab to Standard TPF Regimen in Locally Advanced Head and Neck Cancer: A Single Institutional Study.
    Koramati SL; Sarathy V; Varayathu H; Thomas BE; Naik R
    J Oncol; 2021; 2021():6641963. PubMed ID: 33953747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.
    Sun Y; Li WF; Chen NY; Zhang N; Hu GQ; Xie FY; Sun Y; Chen XZ; Li JG; Zhu XD; Hu CS; Xu XY; Chen YY; Hu WH; Guo L; Mo HY; Chen L; Mao YP; Sun R; Ai P; Liang SB; Long GX; Zheng BM; Feng XL; Gong XC; Li L; Shen CY; Xu JY; Guo Y; Chen YM; Zhang F; Lin L; Tang LL; Liu MZ; Ma J
    Lancet Oncol; 2016 Nov; 17(11):1509-1520. PubMed ID: 27686945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
    Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A
    Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
    Tao Y; Sun XS; Pointreau Y; Le Tourneau C; Sire C; Kaminsky MC; Coutte A; Alfonsi M; Calderon B; Boisselier P; Martin L; Miroir J; Ramee JF; Delord JP; Clatot F; Rolland F; Villa J; Magne N; Elicin O; Gherga E; Nguyen F; Lafond C; Bera G; Calugaru V; Geoffrois L; Chauffert B; Damstrup L; Crompton P; Ennaji A; Gollmer K; Nauwelaerts H; Bourhis J
    Eur J Cancer; 2023 Apr; 183():24-37. PubMed ID: 36796234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.
    Baghi M; Hambek M; May A; Radeloff A; Gstoettner W; Knecht R
    Anticancer Res; 2006; 26(1B):559-63. PubMed ID: 16739320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
    Langer CJ; Duffy K; Horwitz EM; Litwin S; Rosvold E; Schol J; Keenan E; Nicolaou N; Friedman CD; Ridge JA
    Cancer Invest; 2006 Mar; 24(2):164-73. PubMed ID: 16537186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.